Not exact matches
Consortium principal investigators are Patrick R. Griffin, chair
of the Department
of Molecular Therapeutics and director
of the
Translational Research Institute on the Jupiter, Florida campus
of Scripps
Research; M.G. Finn, a professor in the Department
of Chemistry and the Skaggs Institute for Chemical Biology on the La Jolla, California campus
of Scripps
Research; and
consortium director Athina Markou, a professor in the Department
of Psychiatry at UCSD and adjunct professor in the Scripps
Research Molecular and Integrative Neurosciences Department (MIND).
This
research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of
research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell
Consortium (U01DK103141), a collaborative
research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of
research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute
of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED)
consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and
Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine
Research Center between Emory University, Georgia Tech and the University of
Research Center between Emory University, Georgia Tech and the University
of Georgia.
The Divisions
of Cancer Prevention (DCP) and Cancer Biology (DCB) at the National Institutes
of Health (NIH) has awarded a $ 6 million grant to investigators at the University
of Michigan to continue support for a
Research Center in the Barrett's Esophagus
Translational Research Network (BETRNet)-- this
consortium studies the connection between Barrett's esophagus and risk for developing esophageal cancer.
Acknowledgments We express sincere thanks to the following organizations that have contributed to the CASMI
Translational Stem Cell
Consortium (CTSCC) as funding and events partners, without whom the
consortium and the benefits it will bring to stem cell translation would be constrained: GE Healthcare, the Center for Commercialization
of Regenerative Medicine (CCRM), Sartorius Stedim Biotech (formerly TAP Biosystems), Lonza, the California Institute for Regenerative Medicine (CIRM), the Strategies for Engineered Negligible Senescence (SENS)
Research Foundation, UK Cell Therapy Catapult, NIH Centre for Regenerative Medicine, the New York Stem Cell Foundation (NYSCF), ThermoFisher Scientific, Eisai, Medipost (US), Medipost (Korea), Celgene, Roche and Oxford Biomedica.
«In just a few short years, by analyzing tens
of thousands
of samples, our
consortium has moved from identifying only a handful
of loci associated with schizophrenia, to finding so many that we can see patterns among them,» said first author Stephan Ripke, a scientist at the Broad's Stanley Center for Psychiatric
Research and the Analytical and
Translational Genetics Unit at MGH.
Acknowledgments We express sincere thanks to the following organizations that have contributed to the CASMI
Translational Stem Cell
Consortium (CTSCC) as funding and events partners, without whom the
consortium and the benefits it will bring to stem cell translation would be constrained: GE Healthcare, the Center for Commercialization
of Regenerative Medicine (CCRM), Sartorius Stedim Biotech (formerly TAP Biosystems), Lonza, the California Institute for Regenerative Medicine (CIRM), the Strategies for Engineered Negligible Senescence (SENS)
Research Foundation, UK Cell Therapy Catapult, NIH Centre for Regenerative Medicine, the New York Stem Cell Foundation (NYSCF), ThermoFisher Scientific, Eisai, Medipost (US), Medipost (Korea), Celgene, Roche and Oxford BioMedica (UK) Ltd..
The Clinical and
Translational Science Award (CTSA) program, part
of the NIH's National Center for Advancing
Translational Sciences (NCATS), supports a national
consortium of more than 60 medical
research institutions in 31 states.